Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine

Transplantation

Volumn 84, Issue 2, 2007, Pages 187-195

  Delbridge, Michael S ^a   Shrestha, Badri M ^a   Raftery, Andrew T ^a   El Nahas, A Meguid ^a   Haylor, John L ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

FTY720; Ischemia reperfusion; Lymphocyte; Nonheart beating

Indexed keywords

CREATININE; CYCLOSPORIN; FINGOLIMOD;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HISTOLOGY; KIDNEY GRAFT; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY STRUCTURE; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SKIN INCISION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CREATININE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FOLLOW-UP STUDIES; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROPYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SPHINGOSINE; TREATMENT OUTCOME;

EID: 34547646134     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269794.74990.da     Document Type: Article

References (45)

1. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
2. Hetzel GR, Klein B, Brause M, et al. Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome. Transpl Int 2002; 15: 10.
3. Moreso F, Seron D, Gil-Vernet S, et al. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999; 14: 930.
4. Kreis HA, Ponticelli C. Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors. Transplantation 2001; 71(11 Suppl): SS5.
5. Jablonski P, Harrison C, Howden B, et al. Cyclosporine and the ischemic rat kidney. Transplantation 1986; 41: 147.
6. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995; 59: 962.
7. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int 2003; 64: 864.
8. Massberg S, Messmer K. The nature of ischemia/reperfusion injury. Transplant Proc 1998; 30: 4217.
9. Paller MS. Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 1989; 113: 379.
10. Morpurgo E, Cadrobbi R, Morpurgo M, et al. Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury. Transplantation 1996; 62: 1221.
11. Hansson R, Johansson S, Jonsson O, Pettersson S, Schersten T, Waldenstrom J. Kidney protection by pretreatment with free radical scavengers and allopurinol: Renal function at recirculation after warm ischaemia in rabbits. Clin Sci (Lond) 1986; 71: 245.
12. Singbartl K, Green SA, Ley K. Blocking P-selectin protects from ischemia/ reperfusion-induced acute renal failure. Faseb J 2000; 14: 48.
13. Dragun D, Tullius SG, Park JK, et al. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 1998; 54: 590.
14. Kelly KJ, Williams WW, Jr., Colvin RB, Bonventre JV. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 1994; 91: 812.
15. Martin X, Da Silva M, Virieux SR, et al. Protective effect of an anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation. Transplant Proc 2000; 32: 481.
16. Rabb H, Daniels F, O'Donnell M, et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279: F525.
17. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279.
18. Yokota N, Daniels F, Crosson J, Rabb H. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 2002; 74: 759.
19. Kunzendorf U, Ziegler E, Kabelitz D. FTY720-the first compound of a new promising class of immunosuppressive drugs. Nephrol Dial Transplant 2004; 19: 1677.
20. Nemoto T, Burne MJ, Daniels F, et al. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int 2001; 60: 2205.
21. Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man: Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 1979; 58: 362.
22. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15: 1562.
23. Ysebaert DK, De Greef KE, De Beuf A, et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66: 491.
24. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 100: 1199.
25. Troncoso P, Ortiz M, Martinez L, Kahan BD. FTY 720 prevents ischemic reperfusion damage in rat kidneys. Transplant Proc 2001; 33: 857.
26. Suleiman M, Cury PM, Pestana JO, Burdmann EA, Bueno V. FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury. Transplant Proc 2005; 37: 373.
27. Dragun D, Bohler T, Nieminen-Kelha M, et al. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int 2004; 65: 1076.
28. Daemen MA, de Vries B, Buurman WA. Apoptosis and inflammation in renal reperfusion injury. Transplantation 2002; 73: 1693.
29. Burns AT, Davies DR, McLaren AJ, Cerundolo L, Morris PJ, Fuggle SV. Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation 1998; 66: 872.
30. Daemen MA, van't Veer C, Wolfs TG, Buurman WA. Ischemia/reperfusion- induced IFN-gamma up-regulation: Involvement of IL-12 and IL-18. J Immunol 1999; 162: 5506.
31. Daemen MA, van 't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999; 104: 541.
32. Brinkmann V, Cyster JG, Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 2004; 4: 1019.
33. Brinkmann V, Davis MD, Heise CE, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002; 277: 21453.
34. Brinkmann V. FTY720: Mechanism of action and potential benefit in organ transplantation. Yonsei Med J 2004; 45: 991.
35. Suzuki S. FTY720: Mechanisms of action and its effect on organ transplantation (review). Transplant Proc 1999; 31: 2779.
36. Awad AS, Ye H, Huang L, et al. Selective sphingosine 1-phosphate 1 (S1P1) receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006; 290: F1516.
37. Tolle M, Levkau B, Keul P, et al. Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res 2005; 96: 913.
38. Ishimura T, Fujisawa M, Isotani S, Iijima K, Yoshikawa N, Kamidono S. Endothelial nitric oxide synthase expression in ischemia-reperfusion injury after living related-donor renal transplantation. Transpl Int 2002; 15: 635.
39. Sanchez-Perez-Verdia E, Lopez-Neblina F, Portilla E, Ortiz GG, Gonzalez-Ojeda A, Alvares R. Exogenous nitric oxide protects kidney from ischemia/reperfusion. J Invest Surg 2001; 14: 313.
40. Sola R, Alarcon A, Jimenez C, Osuna A. The influence of delayed graft function. Nephrol Dial Transplant 2004; 19 (Suppl 3): iii32.
41. Takai K, Kishi Y, Fujikawa K, Uchiyama K, Tsuchida M, Naito K. Delayed graft function after renal transplantation from a non-heartbeating donors. Transplant Proc 2003; 35: 89.
42. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859.
43. Gueler F, Gwinner W, Schwarz A, Haller H. Long-term effects of acute ischemia and reperfusion injury. Kidney Int 2004; 66: 523.
44. Troppmann C, Gillingham KJ, Gruessner RW, et al. Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 1996; 61: 1331.
45. Gjertson DW. Impact of delayed graft function and acute rejection on kidney graft survival. Clin Transpl 2000: 467.